Abstract
5062 Background: TLK286 (Telcyta) is a glutathione analog prodrug activated by GST P1–1, which is overexpressed in ovarian cancer. Activation by GST P1–1 releases two electrophilic fragments that i...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
